Concepts (140)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Multiple Organ Failure | 10 | 2024 | 141 | 4.200 |
Why?
|
| Intensive Care Units, Pediatric | 8 | 2025 | 476 | 1.280 |
Why?
|
| Critical Illness | 9 | 2025 | 599 | 1.100 |
Why?
|
| Severity of Illness Index | 5 | 2018 | 2900 | 0.810 |
Why?
|
| Critical Care | 3 | 2022 | 655 | 0.760 |
Why?
|
| Organ Dysfunction Scores | 4 | 2024 | 48 | 0.600 |
Why?
|
| Gastrointestinal Diseases | 1 | 2022 | 336 | 0.580 |
Why?
|
| Muscle Weakness | 1 | 2017 | 84 | 0.550 |
Why?
|
| Muscular Diseases | 1 | 2017 | 104 | 0.540 |
Why?
|
| Child | 24 | 2025 | 24170 | 0.510 |
Why?
|
| Hospital Mortality | 4 | 2020 | 1022 | 0.460 |
Why?
|
| Patient Admission | 2 | 2019 | 184 | 0.450 |
Why?
|
| Disease Progression | 2 | 2017 | 2058 | 0.440 |
Why?
|
| Intestinal Diseases | 1 | 2015 | 83 | 0.440 |
Why?
|
| Pediatrics | 3 | 2017 | 1143 | 0.410 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2012 | 79 | 0.380 |
Why?
|
| Medical Errors | 1 | 2012 | 155 | 0.350 |
Why?
|
| Enteral Nutrition | 2 | 2025 | 256 | 0.350 |
Why?
|
| Monitoring, Physiologic | 3 | 2017 | 376 | 0.350 |
Why?
|
| Intestinal Mucosa | 1 | 2015 | 777 | 0.330 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2012 | 313 | 0.320 |
Why?
|
| Biomarkers | 2 | 2017 | 3083 | 0.320 |
Why?
|
| Malnutrition | 2 | 2025 | 205 | 0.320 |
Why?
|
| Cytokines | 1 | 2015 | 1286 | 0.310 |
Why?
|
| Acute Kidney Injury | 2 | 2025 | 635 | 0.280 |
Why?
|
| Nutritional Support | 2 | 2025 | 54 | 0.270 |
Why?
|
| Attitude of Health Personnel | 1 | 2012 | 660 | 0.270 |
Why?
|
| Heart Defects, Congenital | 2 | 2017 | 1816 | 0.270 |
Why?
|
| Child, Preschool | 12 | 2025 | 13882 | 0.270 |
Why?
|
| Physicians | 1 | 2012 | 581 | 0.250 |
Why?
|
| Chronic Disease | 1 | 2010 | 1191 | 0.250 |
Why?
|
| Infant | 10 | 2025 | 12381 | 0.240 |
Why?
|
| Humans | 25 | 2025 | 124700 | 0.240 |
Why?
|
| Water-Electrolyte Balance | 1 | 2025 | 82 | 0.230 |
Why?
|
| Cardio-Renal Syndrome | 1 | 2024 | 15 | 0.230 |
Why?
|
| Adolescent | 13 | 2025 | 19216 | 0.220 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2024 | 77 | 0.210 |
Why?
|
| Parenteral Nutrition | 1 | 2025 | 194 | 0.210 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2023 | 28 | 0.200 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2022 | 109 | 0.180 |
Why?
|
| Nutritional Status | 2 | 2025 | 314 | 0.180 |
Why?
|
| Hemodynamics | 1 | 2024 | 852 | 0.170 |
Why?
|
| Communicable Diseases | 1 | 2022 | 159 | 0.170 |
Why?
|
| Survival Rate | 2 | 2019 | 2055 | 0.170 |
Why?
|
| Statistics, Nonparametric | 2 | 2012 | 434 | 0.170 |
Why?
|
| Gastrointestinal Tract | 1 | 2022 | 216 | 0.160 |
Why?
|
| Male | 14 | 2025 | 61314 | 0.160 |
Why?
|
| Nervous System Diseases | 1 | 2023 | 375 | 0.150 |
Why?
|
| Female | 14 | 2025 | 66570 | 0.150 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2025 | 612 | 0.150 |
Why?
|
| Respiratory Muscles | 1 | 2017 | 8 | 0.150 |
Why?
|
| Hyperglycemia | 1 | 2020 | 225 | 0.150 |
Why?
|
| Phosphorus | 1 | 2017 | 56 | 0.140 |
Why?
|
| Antitoxins | 1 | 2017 | 7 | 0.140 |
Why?
|
| Nutrition Therapy | 1 | 2017 | 12 | 0.140 |
Why?
|
| Blood Pressure Determination | 1 | 2017 | 110 | 0.130 |
Why?
|
| Extracorporeal Circulation | 1 | 2017 | 56 | 0.130 |
Why?
|
| Airway Extubation | 1 | 2017 | 66 | 0.130 |
Why?
|
| Arterial Pressure | 1 | 2017 | 112 | 0.130 |
Why?
|
| Influenza, Human | 1 | 2022 | 656 | 0.130 |
Why?
|
| Logistic Models | 2 | 2012 | 1807 | 0.130 |
Why?
|
| Steroids | 1 | 2017 | 201 | 0.130 |
Why?
|
| Time Factors | 2 | 2019 | 6323 | 0.120 |
Why?
|
| Stroke | 1 | 2023 | 986 | 0.120 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2017 | 292 | 0.110 |
Why?
|
| Retrospective Studies | 5 | 2025 | 16262 | 0.110 |
Why?
|
| Antioxidants | 1 | 2017 | 369 | 0.110 |
Why?
|
| Sepsis | 1 | 2018 | 479 | 0.110 |
Why?
|
| Postoperative Period | 1 | 2015 | 333 | 0.110 |
Why?
|
| Risk Assessment | 3 | 2018 | 3444 | 0.110 |
Why?
|
| Patient Readmission | 1 | 2017 | 385 | 0.110 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 1236 | 0.110 |
Why?
|
| Hypoglycemic Agents | 1 | 2017 | 444 | 0.100 |
Why?
|
| Cardiac Catheterization | 1 | 2017 | 634 | 0.100 |
Why?
|
| Risk Factors | 3 | 2019 | 10249 | 0.100 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 1437 | 0.100 |
Why?
|
| Patient Discharge | 2 | 2022 | 489 | 0.100 |
Why?
|
| Body Mass Index | 1 | 2018 | 1562 | 0.100 |
Why?
|
| Work Schedule Tolerance | 1 | 2012 | 38 | 0.100 |
Why?
|
| Incidence | 2 | 2010 | 3115 | 0.100 |
Why?
|
| Hospitalists | 1 | 2012 | 45 | 0.090 |
Why?
|
| Organizational Culture | 1 | 2012 | 95 | 0.090 |
Why?
|
| Models, Biological | 1 | 2017 | 1460 | 0.090 |
Why?
|
| Health Care Surveys | 1 | 2012 | 285 | 0.090 |
Why?
|
| United States | 4 | 2023 | 10866 | 0.090 |
Why?
|
| Workload | 1 | 2012 | 145 | 0.090 |
Why?
|
| Fatigue | 1 | 2012 | 191 | 0.090 |
Why?
|
| Cohort Studies | 2 | 2024 | 4799 | 0.090 |
Why?
|
| Vital Signs | 1 | 2010 | 20 | 0.080 |
Why?
|
| Fellowships and Scholarships | 1 | 2012 | 279 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2009 | 588 | 0.070 |
Why?
|
| Patient Safety | 1 | 2012 | 400 | 0.070 |
Why?
|
| Prospective Studies | 2 | 2017 | 6132 | 0.070 |
Why?
|
| Inflammation | 1 | 2015 | 1440 | 0.070 |
Why?
|
| Heart Failure | 1 | 2020 | 2297 | 0.070 |
Why?
|
| Treatment Outcome | 2 | 2020 | 12363 | 0.060 |
Why?
|
| Nutrition Assessment | 1 | 2025 | 135 | 0.060 |
Why?
|
| Infant, Newborn | 3 | 2025 | 8162 | 0.050 |
Why?
|
| Hospitalization | 2 | 2022 | 1775 | 0.050 |
Why?
|
| DEAD Box Protein 58 | 1 | 2022 | 12 | 0.050 |
Why?
|
| Renal Replacement Therapy | 1 | 2024 | 142 | 0.050 |
Why?
|
| Receptors, Immunologic | 1 | 2022 | 112 | 0.050 |
Why?
|
| Internship and Residency | 1 | 2012 | 1175 | 0.050 |
Why?
|
| Interferons | 1 | 2022 | 125 | 0.050 |
Why?
|
| Aftercare | 1 | 2022 | 146 | 0.050 |
Why?
|
| Vaccines, Synthetic | 1 | 2022 | 317 | 0.040 |
Why?
|
| Young Adult | 2 | 2025 | 9022 | 0.040 |
Why?
|
| Prognosis | 1 | 2010 | 4620 | 0.040 |
Why?
|
| Choline O-Acetyltransferase | 1 | 1999 | 13 | 0.040 |
Why?
|
| Cholinergic Fibers | 1 | 1999 | 9 | 0.040 |
Why?
|
| Acetylcholinesterase | 1 | 1999 | 24 | 0.040 |
Why?
|
| Auditory Pathways | 1 | 1999 | 20 | 0.040 |
Why?
|
| Pons | 1 | 1999 | 32 | 0.040 |
Why?
|
| South America | 1 | 2018 | 39 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2022 | 458 | 0.040 |
Why?
|
| Inpatients | 1 | 2023 | 495 | 0.040 |
Why?
|
| Asia | 1 | 2018 | 107 | 0.040 |
Why?
|
| North America | 1 | 2018 | 239 | 0.040 |
Why?
|
| Evidence-Based Medicine | 1 | 2022 | 632 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 5154 | 0.040 |
Why?
|
| Europe | 1 | 2018 | 353 | 0.040 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 461 | 0.030 |
Why?
|
| Cardiac Output | 1 | 2017 | 171 | 0.030 |
Why?
|
| Equipment Design | 1 | 2017 | 598 | 0.030 |
Why?
|
| Pandemics | 1 | 2023 | 1104 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2022 | 3292 | 0.030 |
Why?
|
| Insulin | 1 | 2020 | 1204 | 0.030 |
Why?
|
| Length of Stay | 1 | 2020 | 1305 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2022 | 2634 | 0.030 |
Why?
|
| Comorbidity | 1 | 2018 | 1530 | 0.030 |
Why?
|
| Diagnostic Errors | 1 | 2017 | 332 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 1357 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2017 | 1176 | 0.020 |
Why?
|
| Prevalence | 1 | 2018 | 2446 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 2885 | 0.020 |
Why?
|
| Neurons | 1 | 1999 | 1932 | 0.020 |
Why?
|
| Adult | 1 | 2024 | 29555 | 0.010 |
Why?
|
| Mesocricetus | 1 | 1999 | 72 | 0.010 |
Why?
|
| Cricetinae | 1 | 1999 | 422 | 0.010 |
Why?
|
| Animals | 1 | 1999 | 34234 | 0.000 |
Why?
|